From: Dana Okafor <d.okafor@example-pharmacy.test>
To: drugsafety@harrowgate.example
Subject: Possible reaction to Veltarin
Date: 8 September 2026

Hello,

I am a community pharmacist at Riverside Pharmacy. I want to report a reaction in one of our customers, initials M.R., a 67-year-old woman.
She started Veltarin 50 mg once daily on 20 August 2026 for her arthritis. She also takes amlodipine 5 mg daily.
On 1 September 2026 she woke up with swelling of her lips and tongue and had trouble swallowing. Her daughter took her to the emergency department and she was admitted overnight.
In hospital she was given IV hydrocortisone and an antihistamine, and the swelling went down by the next morning. The hospital told her to stop Veltarin and she has not taken it since.
She has now recovered.
I mentioned this to your sales representative when he visited the pharmacy on 2 September 2026, and he asked me to email the details here.
You can reach me at 555-0142.

Dana Okafor, PharmD